Atect Corp operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atect Corp with three other
pharmaceutical manufacturers in Asia:
Pharma Foods International Co.Ltd
sales of 10.53 billion Japanese Yen [US$96.80 million]
of which 81%
was Functional product(Online business)),
Hester Pharmaceuticals Limited
(1.78 billion Indian Rupees [US$24.68 million]
of which 73%
was Poultry Vaccines), and
Panacea Biotec Ltd
based in India
(4.51 billion Indian Rupees [US$62.44 million]
of which 80%
Atect Corp reported sales of ¥2.96 billion (US$27.16 million)
March of 2019.
increase of 10.7%
versus 2018, when the company's sales were ¥2.67 billion.
This was the fourth straight year of sales growth at Atect Corp.